Approved For Marketing EXPANDED_ACCESS NCT01327742

Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients With Thoracic Aortic Pathologies

Sponsor: Bolton Medical

Conditions Penetrating Ulcers Thoracic Aortic Aneurysm

Interventions Relay Thoracic Stent-Graft

Updated 8 times since 2017 Last updated: Nov 16, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01327742, this observational or N/A phase trial focuses on Penetrating Ulcers and Thoracic Aortic Aneurysm and remains ongoing. Sponsored by Bolton Medical, it has been updated 8 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Approved For Marketing
Sep 2024 — Sep 2025 [monthly]

Approved For Marketing
Jul 2024 — Sep 2024 [monthly]

Approved For Marketing
Jan 2021 — Jul 2024 [monthly]

Approved For Marketing
Jun 2018 — Jan 2021 [monthly]

Approved For Marketing

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Approved For Marketing

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Approved For Marketing NA
Jan 2017 — Feb 2017 [monthly]

Approved For Marketing NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bolton Medical

Data source: Bolton Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Boston, United States , Chapel Hill, United States , Cleveland, United States , Columbus, United States , Gainesville, United States , Greenville, United States , Indianapolis, United States , Miami, United States , Norfolk, United States and 5 more locations